Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 1,301–1,400 of 2,099
IUGR with catch-up growth programs impaired insulin sensitivity through LRP6/IRS-1 in male rats
Long, W., Zhou, T., Xuan, X., Cao, Q., Luo, Z., Qin, Y., Ning, Q., Luo, X., & Xie, X. (2021) · Endocrine Connections · doi:10.1530/ec-21-0203 · Cited by 9
Chromium chloride increases insulin‐stimulated glucose uptake in the perfused rat hindlimb
Doerner, P. G., Liao, Y. ‐., Ding, Z., Wang, W., Ivy, J. L., & Bernard, J. R. (2014) · Acta Physiologica · doi:10.1111/apha.12375 · Cited by 7
Heger, V., Benesova, B., Viskupičová, J., Májeková, M., Zoofishan, Z., Hunyadi, A., & Horáková, Ľ. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00047 · Cited by 8
Possible Molecular Targets of Cinnamon in the Insulin Signaling Pathway
Eijaz, S., Salim, A., & Waqar, M. A. (2014) · Journal Of Biochemical Technology · doi:10.51847/dppbjnl · Cited by 8
Grundy, S. M. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_3 · Cited by 7
Pathogenesis of Type 2 Diabetes Mellitus
Kalin, M. F., Goncalves, M., John‐Kalarickal, J., & Fonseca, V. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_13-2 · Cited by 11
White, M. F. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch8 · Cited by 12
Personalized Molecular Signatures of Insulin Resistance and Type 2 DiabetesPreprint
Larsen, J. K., Stocks, B., Henderson, J., Andersson, D. P., Bäckdahl, J., Hogling, D. E., Stidsen, J. V., Sakamoto, K., Højlund, K., Rydén, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.06.578994 · Cited by 7
Contribution of skeletal muscle-specific microRNA-133b to insulin resistance in heart failure
Velásquez, F. C., Román, B., Hernández‐Ochoa, E. O., Leppo, M. K., Truong, S. K., Steenbergen, C., Schneider, M. F., Weiss, R. G., & Das, S. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00250.2022 · Cited by 6
Jang, J., Kim, Y., Song, T., Park, S., Kim, H., Koh, J., Cho, Y., Park, S., Sadayappan, S., Kwak, H., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13519 · Cited by 9
“38 Thus, it is expected that increased muscle mass and/or function are expected to improve glucose metabolism.”
BackgroundKhan, S., Klochko, C. L., Cooper, S., Franz, B. M., Wolf, L., Alessio, A. M., & Soliman, S. B. (2024) · Journal of Medical Ultrasound · doi:10.4103/jmu.jmu_12_24 · Cited by 9
“[15,30] Myosteatosis, both intermuscular and intramuscular, as seen with aging, disuse, atrophy, and obesity has been shown to cause a sonographic hyperechoic muscle.”
Qiao, J., Chen, X., Pang, J., Fei, H., Liu, Z., Cheng, F., Chen, Q., Zhao, Y., Shi, F., Jia, H., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1514660 · Cited by 7
Młynarska, E., Leszto, K., Katańska, K., Prusak, A., Wieczorek, A., Jakubowska, P., Rysz, J., & Franczyk, B. (2025) · Nutrients · doi:10.3390/nu17172860 · Cited by 11
Carlsson, M., Frank, E., Màrmol, J. M., Ali, M. S., Raun, S. H., Battey, E., Andersen, N. R., Irazoki, A., Lund, C., Henríquez‐Olguín, C., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102261 · Cited by 8
“Muscle accounts for up to 75% of insulin-stimulated glucose disposal in humans and is therefore crucial for metabolic regulation [2 — 6].”
Wilkinson, M., Rollin, T., Kuriakose, M., Haggerty-Goede, R. A. L., Miller, D. M., & Dunham‐Snary, K. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110370 · Cited by 6
Liu, H., Li, S., Zhang, X., Long, W., Liao, H., Lu, L., Ni, S.-H., & Yang, Z. (2025) · JMIR Aging · doi:10.2196/80115 · Cited by 8
“Skeletal muscle is pivotal for insulin-mediated glucose disposal postmeal [44,45].”
Omar, A. K., Puma, L. C. L., Whitcomb, L. A., Risk, B. D., Witt, A. C., Bruemmer, J. E., Winger, Q. A., Bouma, G. J., & Chicco, A. J. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00059.2023 · Cited by 7
He, Q., Shu, H., Peng, Y., Xu, Y., Liu, L., Zhou, J., Zhao, J., Xiong, X., & Li, C. (2023) · Amino Acids · doi:10.1007/s00726-023-03320-2 · Cited by 7
Ye, X., Liu, R., Qiao, Z., Chai, X., & Wang, Y. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1273342 · Cited by 7
Xu, X., Du, H., Talifu, Z., Zhang, C.-J., Li, Z., Liu, W.-B., Liang, Y.-X., Xu, X., Zhang, J., Yang, D., et al. (2023) · Nutrients · doi:10.3390/nu15214578 · Cited by 6
Unresolved questions in the regulation of skeletal muscle insulin action by reactive oxygen species
Gallero, S., Persson, K. W., & Henríquez‐Olguín, C. (2024) · FEBS Letters · doi:10.1002/1873-3468.14937 · Cited by 7
“Under healthy conditions, skeletal muscle is quantitatively the major site for insulin-stimulated glucose uptake [2].”
Simon‐Szabó, L., Lizák, B., Sturm, G., Somogyi, A., Takács, I., & Németh, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169113 · Cited by 10
“The highest FFA and insulin-dependent glucose consumption is conducted in skeletal muscle, which may explain its key role in whole-body IR as well as the widespread opinion that any defects in the utilization of these energy sources are the primary cause of the development of IR [91,92].”
BackgroundLin, Y., Wang, Y., Zhang, Q., Gao, R., Chang, F., Li, B., Huang, K., Cheng, N., & He, X. (2024) · Biomolecules · doi:10.3390/biom14091193 · Cited by 9
“However, many studies have shown that IR is one of the key triggers of T2DM [4,8,9].”
BackgroundWang, P., Li, J., Li, C. G., Zhou, X., Chen, X., Zhu, M., & Wang, H. (2025) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.70010 · Cited by 7
Are strategies to increase muscle mass and strength as effective in people with type 2 diabetes?
Al-Awadi, A. A., Gray, S. R., & Al‐Ozairi, E. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09947-8 · Cited by 12
“It is also the major amino acid store in the body providing substrates for hepatic gluconeogenic pre-cursors and protein synthesis [53].”
Blackwood, S. J., Tischer, D., Pontén, M., Moberg, M., & Katz, A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf282 · Cited by 8
Henagan, T. M., Stewart, L. K., Forney, L. A., Sparks, L. M., Johannsen, N. M., & Church, T. S. (2014) · PPAR Research · doi:10.1155/2014/895734 · Cited by 6
Brunton, S., Kruger, D. F., & Funnell, M. M. (2016) · Clinical Diabetes · doi:10.2337/diaclin.34.1.34 · Cited by 8
“As the disease progresses, β-cell function declines, and the response to insulin in skeletal muscle and liver cells decreases (13,14).”
BackgroundГеруш, І. В., Bevzo, V. V., & Ferenchuk, Y. O. (2018) · The Ukrainian Biochemical Journal · doi:10.15407/ubj90.03.062 · Cited by 10
Russell‐Guzmán, J., Karachon, L., Gacitúa, T. A., Freundlich, A., Poblete-Aro, C., & Rodrigo, R. (2018) · Sport Sciences for Health · doi:10.1007/s11332-018-0459-9 · Cited by 7
“This triggers a compensatory response from the pancreas, which secretes a higher quantity of insulin, generating hyperinsulinemia [13].”
BackgroundInfluentialFan, H., Li, Y., Wang, J., Shao, J., Tang, T., Elzo, M. A., Wang, L., Lai, T., Ma, Y., Gan, M., et al. (2021) · Animals · doi:10.3390/ani11061722 · Cited by 8
Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects
Shannon, C. E., Merovci, A., Fourcaudot, M. J., Tripathy, D., Abdul‐Ghani, M. A., Wang, H., Han, X., Norton, L., & DeFronzo, R. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac306 · Cited by 7
Self-citationKe, J., Hu, X. T., Wang, C., & Zhang, Y. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01195-0 · Cited by 6
“Skeletal muscle insulin resistance, which is defined as less sensitivity of skeletal muscle to normal insulin concentration, aggravates the development of T2DM [4].”
BackgroundAlghanem, L., Zhang, X., Jaiswal, R., Seyoum, B., Mallisho, A., Msallaty, Z., & Yi, Z. (2022) · ACS Omega · doi:10.1021/acsomega.2c04473 · Cited by 7
Acute responsiveness to single leg cycling in adults with obesity
Gries, K. J., Hart, C. R., Kunz, H., Ryan, Z., Zhang, X., Parvizi, M., Liu, Y., Dasari, S., & Lanza, I. R. (2022) · Physiological Reports · doi:10.14814/phy2.15539 · Cited by 5
“…obesity exhibits mitochondrial impairments (Ritov et al., 2005), oxidative stress (Anderson et al., 2009), ectopic lipid accumulation (Kelley & Goodpaster, 2001), and insulin resistance (DeFronzo & Tripathy, 2009) that are believed to contribute to obesity- related comorbidities (Blüher, 2019).”
BackgroundHandy, R. M., DesOrmeaux, G. J., Barbeau, P., Frangos, S. M., & Holloway, G. P. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00196.2022 · Cited by 6
Budd, J. M., Hucik, B., Wang, C., King, A. N., Sarr, O., Nakamura, M., Harasim‐Symbor, E., Chabowski, A., Dyck, D. J., & Mutch, D. M. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00308.2022 · Cited by 6
Kcnma1 is involved in mitochondrial homeostasis in diabetes‐related skeletal muscle atrophy
Gao, S., Liu, Y., Wen, R., Huang, X., Li, P., Yang, Y., Yang, N., & Zhang, T. (2023) · The FASEB Journal · doi:10.1096/fj.202201397rr · Cited by 6
An early, reversible cholesterolgenic etiology of diet-induced insulin resistance
Covert, J. D., Grice, B. A., Thornburg, M. G., Kaur, M., Ryan, A. P., Tackett, L., Bhamidipati, T., Stull, N. D., Kim, T., Habegger, K. M., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101715 · Cited by 8
Mung bean peptides promote glucose uptake via Jak2 activation in L6 myotubes
Yoshioka, Y., Zhang, Q., Wang, X., Kitakaze, T., Yamashita, Y., Kohno, M., & Ashida, H. (2023) · Food & Function · doi:10.1039/d3fo00836c · Cited by 8
Jaquet, M., Bengue, M., Lambert, K., Carnac, G., Missé, D., & Bisbal, C. (2023) · Biochimie · doi:10.1016/j.biochi.2023.09.005 · Cited by 7
Influence of renal function on the ability of TyG Index to predict all-cause mortality
Li, H., Chen, W., Lin, X., Chen, W., Xie, T., Chen, K., Hou, S., & Li, H. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01958-1 · Cited by 7
“Insulin resistance (IR), typically characterized by the diminished responsiveness of target organs to circulating insulin, is a well-acknowledged marker for both metabolic disorders and systemic inflammation [1, 2].”
BackgroundMemelink, R. G., Hijlkema, A., Valentin, B., Streppel, M. T., Pasman, W. J., Wopereis, S., den Bosch, J. D. V., Tieland, M., Schoufour, J. D., Bautmans, I., et al. (2024) · Lifestyle Medicine · doi:10.1002/lim2.103 · Cited by 8
Ríos, E., Samsó, M., Figueroa, L., Manno, C. D., Tammineni, E. R., Giordano, L. R., & Riazi, S. (2024) · The Journal of General Physiology · doi:10.1085/jgp.202413595 · Cited by 6
“The relevance of this metabolic role is reflected in the fact that failure of muscle intake of glucose constitutes the main proximate cause of hyperglycemia and type-2 diabetes (DeFronzo and Tripathy, 2009).”
Yang, X., Peng, J., Sun, F., Wu, P., Wang, Y., Xu, Y., Lai, Y., Yuan, J., Zhang, S., Jiang, L., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae881 · Cited by 5
Habegger, K. M., Matzke, D., Ottaway, N., Hembree, J., Holland, J., Raver, C., Mansfeld, J., Müller, T. D., Pérez–Tilve, D., Pfluger, P. T., et al. (2012) · Adipocyte · doi:10.4161/adip.20891 · Cited by 6
“This hypothesis is supported by the observation that adipose tissue is responsible for less than 5% of the postprandial glucose load.(31) In view of our findings in mice lacking hepatic PKCl, and prior studies in mice deficient for skeletal muscle PKCl(8), these data suggest that adipose PKCl plays a subtle role, if a…”
ResultTreating Diabetes with Exercise – Focus on the Microvasculature
Kolka, C. M. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000308 · Cited by 7
“Skeletal muscle [11] and liver insulin resistance [12] have both been proposed as the primary defect in type 2 diabetes, and the implication is that cellular insulin resistance is the major issue.”
BackgroundVink, H. (2014) · Cited by 11
Mécanismes d’action directs mis en jeu dans les myopathies toxiques
Khelfi, A., Azzouz, M., Abtroun, R., Reggabi, M., & Alamir, B. (2017) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2017.04.002 · Cited by 6
Molecular mechanisms of insulin signaling
Iliya, I., Mohammed, B., Akuyam, S., Nok, A., Bauchi, Z. M., Tanko, M., Timbuak, J., & Yusuf, B. (2016) · Sub-Saharan African Journal of Medicine · doi:10.4103/2384-5147.176267 · Cited by 6
Potential adverse effects of botanical supplementation in high-fat-fed female mice
Fuller, S. E., Yu, Y., Mendoza, T. M., Ribnicky, D., Cefalu, W. T., & Floyd, Z. E. (2018) · Biology of Sex Differences · doi:10.1186/s13293-018-0199-1 · Cited by 6
Marmonti, E., Busquets, S., Toledo, M., Ricci, M., Bria, J., Oliva, F., López-Pedrosa, J., Manzano, M., Rueda, R., López-Soriano, F., et al. (2018) · JCSM Rapid Communications · doi:10.1002/j.2617-1619.2018.tb00007.x · Cited by 6
“Insulin resistance is a characteristic feature of T2DM patients and plays an essential role in the pathogenesis of the disease [29].”
BackgroundWard, K. M., Burghardt, K. J., Kraal, A. Z., Jaeger, A. P., Yeomans, L., McHugh, C. E., Karnovsky, A., Stringer, K. A., & Ellingrod, V. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.623143 · Cited by 6
“Among risk factors for CVD, insulin resistance is important as an early, defining feature of diabetes and metabolic syndrome (3, 4).”
BackgroundTakegami, M., Hashimoto, Y., Hamaguchi, M., Kaji, A., Sakai, R., Okamura, T., Kitagawa, N., Osaka, T., Okada, H., Nakanishi, N., et al. (2022) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.21-152 · Cited by 8
Reyad‐ul‐Ferdous, M., Abdalla, M., Yang, M., Xiaoling, L., Bian, W., Xie, J., & Song, Y. (2022) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2022.101516 · Cited by 6
“lipid and Dyslipidaemia were found abundantly in the liver of obese and insulin-resistant mice [44,45].”
Nagano, N., Kaneko, C., Ohashi, S., Seya, M., Takigawa, I., Masunaga, K., & Morioka, I. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19148560 · Cited by 6
“Skeletal muscle is the main organ that insulin acts on to take up glucose, and accounts for approximately 70% of the total glucose processing capacity of the body [11].”
BackgroundCirculating C-Terminal Agrin Fragment: A Potential Marker for Sarcopenia Among Type 2 Diabetes
Racha, P., Selvam, S., Bose, B., Bantwal, G., & Sambashivaiah, S. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_507_21 · Cited by 7
“This suggests that the circulating CAF level has the potential to be considered as a clinical marker to evaluate sarcopenia among T2D.”
BackgroundInfluentialDecreased RNF41 expression leads to insulin resistance in skeletal muscle of obese women
Breuker, C., Amouzou, C., Fabre, O., Lambert, K., Seyer, P., Bourret, A., Salehzada, T., Mercier, J. G., Sultan, A., & Bisbal, C. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.014 · Cited by 8
Sex Differences in Obesity-Induced Inflammation
Terrazas, S., Brashear, L., Escoto, A.-K., Lynch, S. E., Slaughter, D., Xavier, N., Estes, N. R., & Giordano‐Mooga, S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.84941 · Cited by 8
“The reported sex differences in muscle mass emphasize the differences of maintaining muscle during aging and could represent an important target in women who are at greater risk for sarcopenic obesity given their higher fat and lower muscle mass [63].”
BackgroundNoncanonical Regulation of cAMP‐Dependent Insulin Secretion and Its Implications in Type 2 Diabetes
Ramanadham, S., TURK, J. W., & Bhatnagar, S. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220031 · Cited by 13
“We posit that the study of a link between iPLA 2 β and C1ql3 could elucidate the initial signaling events that contribute to β -cell dysfunction in the IGT state associated with obesity before the clinical diagnosis of T2D (61, 93, 211, 233).”
Ebrahimi, R., & Golestani, A. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30624 · Cited by 14
“Consequently, TRAF2 is able to activate IκB kinase (IKK) and following NF‐κB via TGF‐β‐activated kinase 1 (TAK1) pathway leading to neuroinflammation and neuronal death (Bahiraee et al., 2019; DeFronzo & Tripathy, 2009).”
BackgroundTincknell, J. B., Kugler, B. A., Spicuzza, H., BERGER, N. J. A., Yan, H., You, T., & Zou, K. (2023) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2023-0286 · Cited by 7
Yin, L., Li, F., Xiao, T., Zhang, J., Li, Y., Luo, J., Zhao, J., & Xiong, J. (2025) · Kidney Medicine · doi:10.1016/j.xkme.2025.101005 · Cited by 6
Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management
Bianco, A., Pagliaro, R., Schiattarella, A., Mariniello, D. F., D’Agnano, V., Cianci, R., Nigro, E., Daniele, A., Scialò, F., & Perrotta, F. (2025) · Biomedicines · doi:10.3390/biomedicines13081817 · Cited by 7
“Insulin resistance, driven in part by lipid accumulation, further impairs muscle protein synthesis via the suppression of PI3K-Akt-mTOR signaling [96].”
Early Postpartum Glucose Tolerance Reclassification by Gestational Diabetes Subtype
Van, J. A. D., Lo, J. C.-M., Zhu, Y., King, A. S., Sun, B., Hashimoto-Roth, E., Röst, H. L., Alexeeff, S., Wheeler, M. B., & Gunderson, E. P. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.42668 · Cited by 5
Regulation of Insulin Transcytosis Across Endothelium in Metabolic Health and Disease
Mineo, C., & Shaul, P. W. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.321545 · Cited by 6
Circadian regulation of metabolic homeostasis in physiology and disease
Saito, K., YAMAUCHI, T., & Hiraike, Y. (2025) · The Journal of Biochemistry · doi:10.1093/jb/mvaf084 · Cited by 8
Burton, M. A., Garratt, E. S., Hewitt, M., Sharkh, H. Y., Antoun, E., Westbury, L. D., Dennison, E. M., Harvey, N. C., Cooper, C. C., MacIsaac, J. L., et al. (2023) · Skeletal Muscle · doi:10.1186/s13395-023-00326-y · Cited by 5
“Skeletal muscle IR, which has been reported to be present decades before the onset of β cell failure and symptomatic T2D [15, 16], is caused by desensitization of the muscle to insulin leading to elevated blood glucose levels [16].”
BackgroundNomura, K., Inagaki, S., Muramae, N., Takahashi, H., Abe, K., Kato, K., Kido, Y., & Matsuda, T. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108746 · Cited by 7
Newsom, S. A., & Robinson, M. M. (2024) · Physiological Reports · doi:10.14814/phy2.16093 · Cited by 5
“Drugs and exercise can each impact skeletal muscle, the primary tissue for insulin-stimulated glucose uptake (DeFronzo & Tripathy, 2009), yet there remain key gaps in knowledge regarding their combined effects.”
BackgroundAndersen, L. L., Calatayud, J., Núñez‐Cortés, R., Polo‐López, A., & López‐Bueno, R. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16019 · Cited by 7
“10 Additionally, skeletal muscles are actively involved in energy metabolism, protein synthesis and the production of myokines, which have systemic effects on various physiological processes.”
Circadian rhythms, feeding patterns and metabolic regulation: implications for critical care
Smith, H., & Betts, J. A. (2024) · Proceedings of The Nutrition Society · doi:10.1017/s002966512400750x · Cited by 7
“These effects heighten the risk of type 2 diabetes (T2D), which itself is characterised by blunted circadian oscillations, collectively suggesting that circadian disruption is a defining feature of the insulin-resistant state (34,35) .”
Nakamura, S., Asaba, S., Tanaka, M., & Matsui, T. (2024) · ACS Omega · doi:10.1021/acsomega.4c09030 · Cited by 8
Metabolism and metabolomics in senescence, aging, and age-related diseases: a multiscale perspective
Wang, Z., Zhu, H., & Xiong, W. (2025) · Frontiers of Medicine · doi:10.1007/s11684-024-1116-0 · Cited by 7
Abnormal cardiovascular control during exercise: Role of insulin resistance in the brain
Estrada, J. A., Hori, A., Fukazawa, A., Ishizawa, R., Hotta, N., Kim, H., Smith, S. A., & Mizuno, M. (2025) · Autonomic Neuroscience · doi:10.1016/j.autneu.2025.103239 · Cited by 6
Yang, Y., Wang, Y., Chen, Q. Y., Li, L., & Jia, W. (2025) · Brain and Behavior · doi:10.1002/brb3.70267 · Cited by 7
Kim, H. J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041270 · Cited by 10
“Even in the presence of severe insulin resistance, fully functional β -cells can produce sufficient insulin to counterbalance impaired insulin action [19].”
InfluentialPrabakaran, A. D., Chung, H.-J., McFarland, K., Govindarajan, T., Soussi, F., Durumutla, H. B., Villa, C., Piczer, K., Latimer, H., Werbrich, C., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw2593 · Cited by 5
“Skeletal muscle is a major determinant (up to 80 % ) of insulin-mediated glucose disposal and utilization in both humans and rodents ( 8 , 9 ).”
Adiponectin and Adiponectin Signaling
Hadley, J. T., Ryu, J., & Dong, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819801-8.00013-2 · Cited by 8
In vivo antidiabetic potential of standardized Gymnocarpos decandrus Forssk. Extract
El‐Hawary, S. S., Mubarek, M. M., Lotfy, R., Sleem, A. A., & Okba, M. M. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00829-9 · Cited by 8
Insulin Resistance, Secretion and Clearance –Taming the Three Effector Encounter of Type 2 Diabetes
Bar‐Tana, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.741114 · Cited by 5
“The classical paradigm maintains that insulin resistance is the primary defect of T2D, followed by ‘compensatory’ increase in beta cells insulin production (1, 5).”
BackgroundDietary Alterations in Impaired Mitochondrial Dynamics Due to Neurodegeneration
Ashraf, G. M., Chatzichronis, S., Alexiou, A. T., Firdousi, G., Kamal, M. A., & Ganash, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.893018 · Cited by 6
Aspalathin Alleviates Skeletal Muscle Insulin Resistance and Mitochondrial Dysfunction
Mazibuko-Mbeje, S. E., Mthembu, S. X. H., MULLER, C., Ziqubu, K., Muvhulawa, N., Modibedi, R., Tiano, L., & Dludla, P. V. (2022) · Physiological Research · doi:10.33549/physiolres.934844 · Cited by 8
Sorafenib decreases glycemia by impairing hepatic glucose metabolism
Ma, J., Sui, F., Liu, Y., Yuan, M., Dang, H., Liu, R., Shi, B., & Hou, P. (2022) · Endocrine · doi:10.1007/s12020-022-03202-9 · Cited by 7
“Muscle is the major site of postprandial blood glucose consuming [26, 27].”
BackgroundBonafos, B., Cortés-Espinar, A. J., Balas, L., Pessemesse, L., Lambert, K., Benlebna, M., Gaillet, S., Pelletier, F., Delobel, P., Ávila‐Román, J., et al. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109216 · Cited by 5
MG53 : A potential therapeutic target for kidney disease
Ke, B., Shen, W., Song, J., & Fang, X. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1049 · Cited by 5
Khouri, H., Ussher, J. R., & Aguer, C. (2023) · Nutrients · doi:10.3390/nu15194228 · Cited by 5
“In a post-prandial period (when blood glucose is high), insulin signals through insulin receptors in the muscle, which leads to the phosphorylation and activation of a group of proteins including IRS1 (insulin receptor substrate) and AS160 (Akt substrate of 160 kDa) [9].”
BackgroundNakanishi, S., Shimoda, M., Kimura, T., Sanada, J., Fushimi, Y., Iwamoto, Y., Iwamoto, H., Dan, K., Mune, T., Kaku, K., et al. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14200 · Cited by 9
“Skeletal muscle insulin resistance is thought to be the fi rst major de fi ciency that occurs prior to pancreatic b -cell dysfunction and overt hyperglycemia leads to the development of type 2 diabetes mellitus 21 .”
BackgroundProlonged exposure to insulin might cause epigenetic alteration leading to insulin resistance
Bano, S., More, S., Mongad, D., Khalique, A., Dhotre, D. P., Bhat, M. K., & Seshadri, V. (2024) · FEBS Open Bio · doi:10.1002/2211-5463.13891 · Cited by 9
“The conventional view of the history of diabetes suggests a reduced insulin sensitivity followed by increased insulin secretion to maintain glucose homeostasis [5,6].”
Phuong, V. T. M., Quynh, V. T., Di, K. N., Duc, T. Q., & Hoang, N. H. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2436890 · Cited by 6
“A lack of insulin receptors in skeletal muscles has been suggested as the pathophysiology of type 2 diabetes since skeletal muscles are the primary sites of insulin-mediated glucose uptake in the postprandial period [38].”
Zhang, L., Liu, X., Hu, J., Quan, H., Lee, S. K., Korivi, M., Wang, L., Li, T., & Li, W. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00888-8 · Cited by 9
“Skeletal muscle also involved in regulation of insulin signaling pathways, and glycogen synthesis capacity [3–5].”
Glucocorticoid Regulation of Body Composition and Metabolism
Opata, A. A., Cheesman, K. C., & Geer, E. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_1 · Cited by 7
Body composition and personality traits in so-Yang type males
Yoon, J., Nam, J., Leem, C. H., & Kim, J. Y. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1919-5 · Cited by 5
“Among body muscle mass, skeletal muscle plays a crucial role in glucose metabolism and insulin resistance [11].”
BackgroundJørgensen, N. O., Wojtaszewski, J. F. P., & Kjøbsted, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041201 · Cited by 5
“Because muscle insulin resistance is a major cause of metabolic diseases such as type 2 diabetes [2], identifying molecular mechanisms involved in the regulation of muscle insulin sensitivity is central for the development of pharmacological therapies.”
BackgroundOlaniyi, K. S., Sabinari, I. W., & Olatunji, L. A. (2020) · Nutrition · doi:10.1016/j.nut.2020.110789 · Cited by 5
JAYAMOL, M. A., ASHLEY, R., NITHYA, J., & SHIJINA, S. (2020) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2020v12i7.36823 · Cited by 5
“by preventing glucose release from starch and delaying carbohydrate metabolism [17].”
BackgroundThe Role of H2S in the Metabolism of Glucose and Lipids
Sun, H., Wu, Z., Nie, X.-W., & Bian, J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0991-6_3 · Cited by 5
Unique circulating microRNA associations with dysglycemia in people living with HIV and alcohol use
Bourgeois, B. L., Lin, H., Yeh, A. Y., Levitt, D. E., Primeaux, S. D., Ferguson, T. F., Molina, P. E., & Simon, L. (2021) · Physiological Genomics · doi:10.1152/physiolgenomics.00085.2021 · Cited by 6
Lay, A. L., Philippe, E., Roth, F., Sánchez-Archidona, A. R., Mehl, F., Denom, J., Prasad, R. B., Asplund, O., Hansson, O., Ibberson, M. R., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09944 · Cited by 5
“In addition, quanti fi cation of leg muscle glucose uptake in T2D with positron emission tomography has evidenced severe muscle IR [26].”
BackgroundInfluentialSongtrai, S., Dejyong, K., & Kaewsuwan, S. (2022) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres22.1392_10.5.800 · Cited by 5
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.